An open study of the effects of sertraline on adolescent major depression

Journal of Child and Adolescent Psychopharmacology

Volumn 6, Issue 1, 1996, Pages 41-51

  McConville, Brian J ^a,c   Minnery, Kelly L ^a   Sorter, Michael T ^a,b   West, Scott A ^a   Friedman, Loren M ^a   Christian, Karen ^a,b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHENHYDRAMINE; SERTRALINE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DEPRESSION; DROWSINESS; FEMALE; HUMAN; INSOMNIA; MALE;

EID: 0029941153     PISSN: 10445463     EISSN: None     Source Type: Journal    
DOI: 10.1089/cap.1996.6.41     Document Type: Article

References (51)

1. Ambrosini P: K-SADS-P-III-R Present State Version. Unpublished manuscript, 1988
2. Ambrosini P: Diagnostic Criteria Checklist: K-SADS-P DSM-III-R. Unpublished manuscript, July 1992
3. Ambrosini P, Metz C, Prabucki K, Lee JC: Videotaped reliability of the third revised edition of the K-SADS. J Am Acad Child Adolesc Psychiat 28:723-728, 1989
4. Ambrosini P, Bianchi M, Rabinovich H, Elia J: Antidepressant treatments of affective disorders. J Am Acad Child Adolesc Psychiat 32:1-6, 1993
5. Amin M, Lehmann H, Mirmiran J: A double-blind, placebo-controlled dose-finding study with sertraline. Psychopharmacol Bull 25:164-167, 1989
6. Barros J, Asnis G: An interaction of sertraline and desipramine [letter]. Am J Psychiat 150:1751, 1993.
7. Bartko J, Carpenter W: On the methods and theory of reliability. J Nerv Ment Disease 163:307-317, 1976
8. Boulos C, Kutcher S, Gardner D, Young E: An open-naturalistic trial of fluoxetine in adolescents and young adults with treatment-resistant major depression. J Child Adolesc Psychopharmacol 2:103-111, 1992
9. Cohen J: A coefficient of agreement for nominal scales. Education Psychol Measure 20:37-46, 1960
10. Colle L, Belair J, DiFeo M, Weiss J, LaRoche C: Extended open label fluoxetine treatment of adolescents with major depression. J Chlid Adolesc Psychopharmacol 4:225-232, 1994
11. Crewe HK, Lennard MS, Tucker GT, Woods FR, Haddock RE: The effect of selective serotonin re-uptake inhibitors on cytochrome P450-2D6 (CYP2D6) activity in human microsomes. Br J Clin Pharmacol 34:262-265, 1992
12. DeVane C: Pharmacokinetics of the newer antidepressants: Clinical relevance. Am J Med 97 (Suppl 6A):13S-23S, 1994
13. Doogan D, Caillard V: Sertraline, a new antidepressant. J Clin Psychiat 49 (Suppl):46-51, 1988
14. Emslie G, Weinberg W, Kowatch R, Hughes C, Carmody T, Rush J: Fluoxetine treatment of depressed children and adolescents. Presented at the Annual Meeting of the New Clinical Drug Evaluation Unit (NCDEU), Orlando (FL), June 1995
15. Geller B: Commentary on unexplained deaths of children on Norpramin®. J Am Acad Child Adolesc Psychiat 30:682-684, 1991
16. Geller B, Cooper T, Graham D, Fetner H, Marsteller F, Wells J: Pharmacokinetically designed double-blind placebo-controlled study of nortriptyline in 6 to 12 year olds with major depressive disorder. J Am Acad Child Adolesc Psychiat 31:34-44, 1992
17. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiat 23:56-62, 1960
18. Harvey AT, Preskorn SH: Interaction of serotonin reuptake inhibitors with tricyclic antidepressants [Letter]. Arch Gen Psychiat 52:783-785, 1995
19. Jain U, Birmaher B, Garcia M, Al-Shabbout M, Ryan ND: Fluoxetine in children and adolescents with mood disorders: A chart review of efficacy and adverse effects. J Child Adolesc Psychopharmacol 2:259-265, 1992
20. Jensen PS, Elliott GR (eds): Why don't antidepressants seem to work for depressed adolescents? J Child Adolesc Psychopharmacol 2:7-45, 1992
21. Joshi PT, Walkup JT, Capozzoli JA, Detrinis RB, Coyle JT: The use of fluoxetine in the treatment of major depressive disorder in children and adolescents [abstract]. Annual Meeting of the American Academy of Child and Adolescent Psychiatry, San Francisco, 1991
22. Kashani J, Carlson G, Beck N: Depression, depressive symptoms and depressed mood in a community sample of adolescents. Am J Psychiat 144:931-934, 1987
23. King RA, Riddle MA, Chappell P, Hardin MT, Anderson GM, Lombroso P, Scahill L: Emergence of self-destructive phenomena in children and adolescents during fluoxetine treatment. J Am Acad Child Adolesc Psychiat 30:179-186, 1991
24. Koe K, Weissman A, Welch W, Browne R: Sertraline, 1S,4S-N-Methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-nephthylamine, a new uptake inhibitor with selectivity for serotonin. J Pharmacol Exp Ther 226:686-700, 1983
25. McElroy S, Keck P, Pope H, Hudson J: Pharmacological treatment of kleptomania and bulimia nervosa. J Clin Psychopharmacol 9:358-360, 1989
26. Minnery K, McConville B, West S, Sorter M: Sertraline-induced mania in an adolescent [letter]. J Child Adolesc Psychopharmacol 5:151-153, 1995
27. Montgomery SA, Asberg M: A new depression scale designed to be sensitive to change. Br J Psychiat 134:382-389, 1979
28. Mrazek D: The Family Global Assessment Scale: Reliability and validity. Unpublished manuscript, 1992
29. National Institute of Mental Health: CGI (Clinical Global Impression) scale. Psychopharmacol Bull 21:839-843, 1985
30. Neel E: Preventable sudden death: The "long Q-T syndrome." J Adolesc Health Care 2:49-51, 1981
31. Popper C, Elliott G: Sudden death and tricyclic antidepressants: Clinical considerations for children. J Child Adolesc Psychopharmacol 1:125-132, 1990
32. Popper CW, Zimnitzky B: Sudden death putatively related to desipramine treatment in youth: A fifth case and a review of speculative mechanisms. J Child Adolesc Psychopharmacol 5:283-300, 1995
33. Poznanski EO, Freeman LN, Mokros HB: Children's Depression Rating Scale-Revised. Psychopharmacol Bull 21:979-990, 1985
34. Preskhorn SH: Targeted pharmacotherapy in depression management: Comparative pharmacokinetics of fluoxetine, paroxetine and sertraline. Int Clin Psychopharmacol 9 (Suppl 3): 13-19, 1994
35. Preskhorn SH, Beber JH, Paul JC, Hirschfeld RM: Serious adverse effects of combining fluoxetine and tricyclic antidepressants [letter]. Am J Psychiat 147:532, 1990
36. Reimherr F, Byerley W, Ward M, Lebegue B, Wender P: Sertraline, a selective inhibitor of serotonin uptake for the treatment of outpatients with major depressive disorder. Psychopharmacol Bull 24:200-205, 1988
37. Reimherr F, Chouinard G, Cohn C, Cole J, Itil T, Lapierre Y, Masco H, Mendels J: Antidepressant efficacy of sertraline: A double-blind, placebo and amitriptyline-controlled, multicenter comparison study in outpatients with major depression. J Clin Psychiatr 51 (12, Suppl B):18-27, 1990
38. Rickels K, Schweizer E: Clinical overview of serotonin reuptake inhibitors. J Clin Psychiat 51 (12, Suppl B):9-12, 1990
39. Riddle MA, Geller B, Ryan N: Another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiat 32:792-797, 1993
40. Riddle MA, King RA, Hardin MT, Scahill L, Ort SI, Chappell P, Rasmusson A, Leckman JF: Behavioral side effects of fluoxetine in children and adolescents. J Child Adolesc Psychopharmacol 1:193-198, 1991b
41. Riddle M, Nelson J, Kleinman C, Rasmussen A, Leckman J, Kemp R, Cohen D: Sudden death in children receiving Norpramin®: A review of three reported cases and commentary. J Am Acad Child Adolesc Psychiat 30:104-108, 1991a
42. Ryan N: Heterocyclic antidepressants in children and adolescents. J Child Adolesc Psychopharmacol 1:21-31, 1990
43. Ryan N, Puig-Antich J: Affective illness in adolescence. In: Annual Review of the American Psychiatric Association. Edited by Frances AJ, Hales RE. Washington (DC), American Psychiatric Press, 1986, pp 420-450
44. Shaffer D, Gould M, Brasic J, Ambrosini P, Fisher P, Bird H, Aluwahlia S: A Children's Global Assessment Scale (CGAS) for children 4-16 years of age. Psychopharmacol Bull 21:747-748, 1985
45. Simeon J, Dinicola V, Ferguson H, Copping W: Adolescent depression: A placebo-controlled fluoxetine treatment study and follow up. Prog Neuropsychopharm Biol Psychiat 14:791-795, 1990
46. Spitzer RL, Endicott J, Robins E: Research diagnostic criteria: Rationale and reliability. Arch Gen Psychiat 35:773-782, 1978
47. Spitzer RL, Williams JB, Gibbon M, First M: Structured Clinical Interview for DSM-III-R, Patient Edition. Washington (DC), American Psychiatric Press, 1990
48. Strober M: Effects of imipramine, lithium, and fluoxetine in the treatment of adolescent major depression [abstract]. Annual Meeting, New Clinical Drug Evaluation Unit (NCDEU), National Institute of Mental Health, Washington (DC), May 1989
49. Tierney E, Joshi PT, Llinas JF, Rosenberg LA, Riddle MA: Sertraline for major depression in children and adolescents: Preliminary clinical experience. J Child Adolesc Psychopharmacol 5:13-27, 1995
50. Weller E, Weller R: Mood disorders. In: Child and Adolescent Psychiatry: A Comprehensive Approach. Edited by Lewis M. Baltimore, Williams & Wilkins, 1991, pp 646-664
51. Werry JS: The safety of desipramine [letter]. J Am Acad Child Adolesc Psychiat 33:588-589, 1994